Astaxanthin: A Potential Therapeutic Agent in Cardiovascular Disease

Renal Research Royal Brisbane and Women's Hospital and The University of Queensland School of Medicine, Butterfield Street, Brisbane, Queensland 4029, Australia.
Marine Drugs (Impact Factor: 3.51). 12/2011; 9(3):447-65. DOI: 10.3390/md9030447
Source: PubMed

ABSTRACT Astaxanthin is a xanthophyll carotenoid present in microalgae, fungi, complex plants, seafood, flamingos and quail. It is an antioxidant with anti-inflammatory properties and as such has potential as a therapeutic agent in atherosclerotic cardiovascular disease. Synthetic forms of astaxanthin have been manufactured. The safety, bioavailability and effects of astaxanthin on oxidative stress and inflammation that have relevance to the pathophysiology of atherosclerotic cardiovascular disease, have been assessed in a small number of clinical studies. No adverse events have been reported and there is evidence of a reduction in biomarkers of oxidative stress and inflammation with astaxanthin administration. Experimental studies in several species using an ischaemia-reperfusion myocardial model demonstrated that astaxanthin protects the myocardium when administered both orally or intravenously prior to the induction of the ischaemic event. At this stage we do not know whether astaxanthin is of benefit when administered after a cardiovascular event and no clinical cardiovascular studies in humans have been completed and/or reported. Cardiovascular clinical trials are warranted based on the physicochemical and antioxidant properties, the safety profile and preliminary experimental cardiovascular studies of astaxanthin.

Download full-text


Available from: Robert G Fassett, Jul 05, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In this study the agronomical and chemical characterization of 13 Sicilian biotypes of Thymbra capitata (L.) Cav., grown under the same agricultural and environmental condition, are reported. The main morpho-productive parameters and quali-quantitative profile of essential oils were determined. The essential oils were analyzed by GC-FID and GC-MS. Hierarchical Cluster Analysis and Principal Component Analysis statistical methods were used to group biotypes according to the essential oils chemical composition. The essential oil yield ranged between 4.6 and 8.1 (v/w). 38 essential oil compounds have been identified. The compounds mostly represented were: α-Pinene, Myrcene, α-Terpinene, p-Cymene, γ-Terpinene, Borneol, Carvacrol and β-Caryophyllene. In all biotypes the Carvacrol (67.4-79.5%) was the main compound, confirming that Thymbra capitata is a carvacrol chemotype. The results showed that all Sicilian Thymbra biotypes have a good adaptation to the climatic conditions of the test environment.
    Natural Product Research 12/2014; DOI:10.1080/14786419.2014.997726
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The effect of astaxanthin (3,3'-dihydroxy-s-carotene-4,4'-dione) on alcohol-induced morphological changes in Carassius auratus, as an experimental model, was determined. The yeast Phaffia rhodozyma was used as a source of astaxanthin. The animals were divided into three groups for 30 days: one group was treated with ethanol at a dose of 1.5% mixed in water, the second one with EtOH 1.5% and food enriched with astaxanthin from P. rhodozyma, and the third was a control group. After a sufficient experimental period, the samples were processed using light microscopy and evaluated by histomorphological and histochemical staining, and the data were supported by immunohistochemical analysis, using a wide range of antibodies, such as calbindin, vimentin and alpha-smooth muscle actin. The results show that the alcoholic damage in the kidney led to hypoxia. In contrast, the group fed with astaxanthin from P. rhodozyma showed a normal morphological picture, with better glomeruli organisation and the presence of the area of filtration. Furthermore, the immunohistochemistry has confirmed these results.
    Natural Product Research 12/2014; 29(12):1-5. DOI:10.1080/14786419.2014.979417
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The potential for biodiesel production from microalgal lipids and for CO(2) mitigation due to photoautotrophic growth of microalgae have recently been recognized. Microalgae biomass also has other valuable components, including carbohydrates, long chain fatty acids, pigments and proteins. The microalgae-based carbohydrates consist mainly of cellulose and starch without lignin; thus they can be ready carbon source for the fermentation industry. Some microalgae can produce long chain fatty acids (such as DHA and EPA) as valuable health food supplements. In addition, microalgal pigments and proteins have considerable potential for many medical applications. This review article presents comprehensive information on the current state of these commercial applications, as well as the utilization and characteristics of the microalgal components, in addition to the key factors and challenges that should be addressed during the production of these materials, and thus provides a useful report that can aid the development of an efficient microalgae-based biorefinery process.
    Bioresource Technology 11/2012; 135. DOI:10.1016/j.biortech.2012.10.099

Similar Publications